Welcome to the Committee on Energy and Commerce.

The Energy and Commerce Committee is at the forefront of all issues and policies powering America’s economy, including our global competitive edge in energy, technology, and health care.


The Latest

From the Committee

Jan 22, 2025
Environment
Chairman Griffith Delivers Opening Statement at Subcommittee on Environment Hearing on Revitalizing American Innovation and Enhancing the U.S. Chemical Supply Chain

WASHINGTON, D.C. – Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Environment,delivered the following opening statement at today’s hearing titled A Decade Later: Assessing the Legacy and Impact of the Frank R. Lautenberg Chemical Safety for the 21st Century Act

Subcommittee Chairman Griffith’s opening statement as prepared for delivery:

“I am really looking forward to working with you, Ranking Member Tonko. I am hopeful we can work together on some bipartisan legislation going through this Subcommittee.


SUPPORTING AMERICAN MANUFACTURING

“Today is not only my first hearing as Chair of the Subcommittee, but it is the first subcommittee hearing the House Energy and Commerce Committee is holding to start the 119th Congress. 

“The American people have spoken loud and clear—they’ve had enough of rising prices and a regulatory burden that threatens energy reliability, reduces American competitiveness, and in some cases, makes for stagnant economic growth. 

“In general, I’ve long believed Congress needs to get back into the practice of passing regular authorizations. As Chair of this Subcommittee, it is my goal to modernize some of our major environmental laws and enable predictable, common sense, regulation. 

“I’m glad we’ve hit the ground running with this hearing and hope that we have signaled our commitment to dig into the statutory language to find out where we can make the law work better for all interested parties.

“To that end, today’s hearing will examine the Frank R. Lautenberg Chemical Safety for the 21st Century Act, or the Lautenberg Act. 

“Nearly ten years ago, the Members of this Committee worked tirelessly to develop the Lautenberg Act to reform the Toxic Substances Control Act, often referred to as ‘TSCA.’

“TSCA governs the Environmental Protection Agency, or EPA’s, regulation of new and existing chemicals and the chain of commerce for products containing those chemicals.

“This was no easy row to hoe—the Lautenberg Act made the most significant changes to TSCA since it became law in 1976. The Lautenberg Act enjoyed strong bipartisan support in this Committee before becoming law in 2016. I was proud to be part of that process.

EMBRACING TECHNOLOGICAL INNOVATION

“However, nearly ten years have passed since the Lautenberg Act’s passage. Both Democrat and Republican Administrations at EPA have had the opportunity to implement the Act’s procedures for collecting new information on chemicals, reviewing new chemicals, and for regulating those that the EPA determines pose an  ‘unreasonable risk.’

And each Administration, as we will hear today, has encountered a number of challenges in implementing the Act. 

“In 2023, the Government Accountability Office found that, between 2017 and 2022, EPA completed only 10 percent of the pre-manufacture chemical reviews within the time limit laid out in the Lautenberg Act.  With the ten-year anniversary of the Lautenberg Act’s passage quickly approaching, today’s hearing will provide us an opportunity to learn more about what’s working and what’s not at the EPA’s Office of Pollution Prevention and Toxics.

“And it’s important that we make the most of this opportunity to create that record. Among other things, TSCA, as amended by the Lautenberg Act, governs the EPA’s processes for reviewing new chemicals or in allowing new uses for existing chemicals before those products can be sold to consumers in the United States. Chemicals are part of manufacturing methods and products that we depend on for our everyday life. 

“New chemicals, utilized in a safe manner, not only lead to new products that enhance our quality of life but also are necessary for addressing crucial challenges like harnessing energy resources and treating disease.

“Similarly, our economic competitiveness and national security depend on our ability to innovate and bring new technologies to market safely and efficiently. As chemicals are part of nearly every product, and new chemistries are essential to developing better products, the TSCA regulatory scheme has a profound impact across nearly every sector of our economy. New chemicals and new uses for existing chemicals must undergo EPA review. 

“If these reviews don’t take place in a timely manner, our international competitors could gain an edge, and more production would likely shift overseas. 

“We are fortunate to have a panel of experts joining us to help us pinpoint shortcomings with our current regulatory mechanisms and to discuss potential opportunities for reform.

“Today, we will hear testimony from Mr. Chris John, President and Chief Executive Officer of the American Chemistry Council, or ACC. The ACC serves as an organization of chemical companies who often engage in EPA’s regulatory process, including new chemical reviews.

“Also joining us is Mr. Jeff Moody, the Vice President of Government Relations for the American Fuel and Petrochemical Manufacturers. He will share the experiences of refiners and manufacturers that comply with TSCA  to make the products we depend on every day. 

“We are also glad to have Dr. Richard Engler. Prior to his current role as Director of Chemistry at the ACTA group, Dr. Engler served at the Environmental Protection Agency for 17 years and will be able to share more about the agency staff’s experience implementing the Act.

“Additionally, Dr. Maria Doa, the Senior Director of Chemicals Policy at the Environmental Defense Fund will offer testimony. Before joining the Environmental Defense Fund in 2021, Dr. Do-A served at the Environmental Protection Agency for 30 years, working on chemical safety and TSCA.”

###



More News & Announcements


Jan 22, 2025
Press Release

Subcommittee on Environment Holds Hearing on Enhancing the U.S. Chemical Supply Chain

WASHINGTON, D.C.  – Today, Congressman Morgan Griffith (VA-09), Chairman of the Subcommittee on Environment, led a hearing titled  A Decade Later: Assessing the Legacy and Impact of the Frank R. Lautenberg Chemical Safety for the 21st Century Act . Chairman Griffith issued the following statement following the hearing: “Each administration has encountered a number of challenges in implementing the Frank R. Lautenberg Chemical Safety for the 21st Century Act,”   said Chairman Griffith .  “Today, the Environment Subcommittee rightly explored these issues and underscored the need to revise the EPA regulatory structure for the uses of new and existing chemicals and for products containing those chemicals.” Watch the full hearing  here . Below are key excerpts from today’s hearing: Vice Chairman Dan Crenshaw (TX-02) : “I just want start off by noting how important chemicals are to a strong economy, they are essential in making all of the products that are necessary for our modern life in the 21st century. Even the word chemicals elicits a pretty visceral negative reaction from many. But we have to remember that we have to put emotions aside and actually acknowledge that chemicals play an indispensable role in creating everything from lifesaving medical devices, to computers, smartphones, and cutting-edge military platforms. The domestic chemical industry supports hundreds of thousands of high paying jobs that generates hundreds of billions of dollars in economic activity. And unfortunately, the prior administration poorly implemented chemical regulations under the Toxic Substances Control Act, putting all of this at risk. Impractical, duplicative or overburdensome regulations for existing chemicals threaten critical supply chains for the products that we all know and rely upon every single day.” Congresswoman Mariannette Miller-Meeks, M.D. (IA-02) : “This subcommittee has the responsibility of addressing the aggressive overregulation of the chemicals industry by the Biden administration, which has severely hindered American companies' ability to innovate, grow, and compete in the global market. I believe this hearing is a strong step in the right direction toward achieving that goal. Dr. Doa said that the EPA wouldn't restrict vinegar, but let me give you an example of aggressive overregulation. I'm both a former operating room nurse and a doctor. When the EPA came out with its rules on ethylene oxide, which is the source for non-steam sterilization with no alternative in place, what was the assessment of the best available science? What was the assessment and evaluation of risks and the cost? Was it better to have people have non-sterilized equipment put in their bodies, risk infection, sepsis, and death? I would say that is an example of overzealous regulation.” Congresswoman Julie Fedorchak (ND-AL) : “We all want to make America safer for our children, and I agree with my colleagues that we should always be trying to do better. But let's be clear, this change in approach from the EPA is a sea change in approach, and it creates more regulatory uncertainty and makes Americans less safe, not more safe, by pushing manufacturing overseas, jeopardizing American jobs, threatening supply chains, exposing them to intrusion by foreign adversaries, driving up costs for North Dakota farmers and ranchers, and thereby for everything that we purchase. These are real impacts and real risks for American families, and I appreciate that the EPA is taking a cumulative risk assessment of chemicals.”  ###



Jan 22, 2025
Press Release

Chairman Guthrie Applauds White House Announcement of $500 Billion Investment in AI Infrastructure

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the Committee on Energy and Commerce, issued the following statement after the White House announced a $500 billion investment by private companies in U.S. AI infrastructure: “This massive investment in American infrastructure makes clear that the United States is prepared to lead the world in next-generation technologies. The Committee on Energy and Commerce is already working on addressing the many challenges that accompany increased investment in AI technology, including the exponentially increasing demand for energy, the need for permitting reform, and the importance of securing Americans’ data, among many others,”  said Chairman Guthrie .  “The commitment announced this week is proof that industry leaders are ready to work with Congressional Republicans and President Trump to spark an economy that creates jobs, supports our communities, and provides opportunities for all Americans.” ###



Jan 20, 2025
Press Release

Chairman Guthrie: “President Trump is Unleashing American Energy Dominance”

WASHINGTON, D.C.  – Today, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, released the following statement on President Trump’s Executive Orders supporting the production of American energy: “On his first day in office, President Trump is already delivering on his promise to increase baseload power, lower costs, and deliver real results for the American people,”   said Chairman Guthrie .  “Today’s executive orders will expand production of American energy sources by incentivizing new investments and unlocking the potential of our natural resources to drive innovation and lower consumer costs. This return to energy dominance is critical to safeguarding national security and creating a strong economy for the people we serve. “As the Chairman of the Committee on Energy and Commerce, I’m thrilled to get to work with President Trump and his administration to create jobs, unleash American energy, and develop new and innovative technologies.” ###


Trending Subcommittees

Commerce, Manufacturing, and Trade


3 Updates

Interstate and foreign commerce, including all trade matters within the jurisdiction of the full committee; consumer protection, including privacy matters generally; data security; motor vehicle safety; regulation of commercial practices (the Federal Trade Commission), including sports-related matters; consumer product safety (the Consumer Product Safety Commission); product liability; and regulation of travel, tourism, and time. The Subcommittee’s jurisdiction can be directly traced to Congress’ constitutional authority “to regulate Commerce with foreign nations, and among the several States, and with the Indian Tribes.”


Communications & Technology


5 Updates

Electronic communications, both Interstate and foreign, including voice, video, audio and data, whether transmitted by wire or wirelessly, and whether transmitted by telecommunications, commercial or private mobile service, broadcast, cable, satellite, microwave, or other mode; technology generally; emergency and public safety communications; cybersecurity, privacy, and data security; the Federal Communications Commission, the National Telecommunications and Information Administration, the Office of Emergency Communications in the Department of Homeland Security; and all aspects of the above-referenced jurisdiction related to the Department of Homeland Security.


Energy


4 Updates

National Energy Policy, energy infrastructure and security, energy related Agencies and Commissions, all laws, programs, and government activities affecting energy matters. National Energy Policy focuses on fossil energy; renewable energy; nuclear energy; energy conservation, utility issues, including but not limited to interstate energy compacts; energy generation, marketing, reliability, transmission, siting, exploration, production, efficiency, cybersecurity, and ratemaking for all generated power. Energy infrastructure and security focuses on pipelines, the strategic petroleum reserve, nuclear facilities, and cybersecurity for our nation’s grid. Our jurisdiction also includes all aspects of the above-referenced jurisdiction related to the Department of Homeland Security. Agencies and Commissions in our jurisdiction include: The US Department of Energy, the Nuclear Regulatory Commission; and the Federal Energy Regulatory Commission.


Recent Letters


Jan 6, 2025
Press Release

Chairman Guthrie and Chairman Latta Question Energy Department’s Involvement in Biden-Harris Offshore Drilling Ban

WASHINGTON, D.C.  – Yesterday, Congressman Brett Guthrie (KY-02), Chairman of the House Committee on Energy and Commerce, along with Congressman Bob Latta (OH-05), Chairman of the Subcommittee on Energy, penned a letter to Secretary Jennifer Granholm questioning the Department of Energy’s involvement in the Biden-Harris Administration’s decision to prevent new offshore oil and gas production, leading to higher prices for consumers and harming U.S. energy security. KEY LETTER EXCERPT: “Closing off swaths of U.S. offshore areas to energy production, as the Biden-Harris Administration reportedly intends to do, will lead to higher energy prices for American families, the loss of American jobs, and greatly diminish our country’s energy security. As the Secretary of Energy, you have an obligation to weigh in on this matter and insist on a full review of the energy security and economic impacts before any decisions are finalized. “The United States stands at an energy crossroads, facing mounting global security threats and soaring demand for power. Instead of leading the world in energy production, we’ve allowed misguided “green” policies to hamstring our potential. It’s time to unleash American energy dominance again—the federal government must become an ally, not an obstacle, to our nation’s energy security. We look forward to your prompt response to this request, no later than January 10, 2025.” Read the story  here . BACKGROUND: This morning, the Biden Administration announced that more than 625 million square miles of coastline would be off-limits for energy production. Republican Members of the House Committee on Energy and Commerce have continuously called on the Biden-Harris Administration to end its attack on American energy production before leaving office on January 20th. The letter requests an explanation of the DOE’s involvement in the decision and whether the White House or the Department of Interior consulted with the DOE about the plans to close off access to offshore resources. Any decision to shut down access to significant American energy resources impacts U.S. energy policy and should be reviewed by the DOE. The Biden Administration’s energy policies have continued to create major harm to America’s energy production and workforce. A unilateral ban on energy production in large swaths of the U.S. coastline will have lasting impacts on American energy production and security.



Dec 19, 2024
Press Release

E&C Republicans Request HHS Watchdog Investigate Promotion of Gender Transition Procedures for Children

Washington, D.C. — In a new letter to Department of Health and Human Services (HHS) Inspector General Christi Grimm, House Energy and Commerce Committee Republicans requested an investigation into the strength, quality, and types of evidence-based scientific and pediatric medical literature relied on by the department to promote gender transition procedures for children.  KEY LETTER EXCERPT:  “As the agency responsible for safeguarding the health and well-being of Americans, all of HHS’s medical treatment recommendations, especially medical treatment recommendations for children, should be based on rigorous and well-established research, such as randomized controlled trials, that have definitively illustrated the long-term benefits of gender affirming care treatments.”  BACKGROUND:  Under the Biden administration, HHS has advocated for sex reassignment procedures on minors, including the use of serum puberty blockers, which have historically been used to treat children with precocious puberty (i.e., early onset puberty affecting about one percent of U.S. children) and sex offenders.   Puberty blockers, however, are known to stunt normal childhood development in children unaffected by precocious puberty.  HHS officials contend that sex reassignment procedures on minors are an unanimously accepted medical practice.  HHS Secretary Becerra testified before Congress that “every major medical association,” “medical journals,” and “scientific and medical evidence” has demonstrated the benefits of transitioning children’s biological sex.  When asked, via a Freedom of Information Act request, for the underlying scientific or medical basis for its position, HHS was only able to produce a two-page brochure that was already publicly available.  In contrast to HHS, a growing body of literature from medical experts and authorities around the world, including those in Europe, caution against performing such procedures on minors.   Courts and government health agencies responsible for determining child welfare have sought to limit child sex reassignment procedures.   Other countries have banned these interventions and surgeries on minors altogether.  An article published in the British Journal of Medicine found “there is great uncertainty about the effects of puberty blockers, cross-sex hormones, and surgeries in young people.”   A court in the United Kingdom noted the obvious about administering puberty blocking chemicals onto children: “[i]t is highly unlikely that a child aged 13 or under would be competent to give consent to the administration of puberty blockers. It is doubtful that a child aged 14 or 15 could understand and weigh the long-term risks and consequences of the administration of puberty blockers.”  In April 2024, the Cass Review , an independent review of gender identity services for children and young people, commissioned by the National Health Service England, found “[w]hile a considerable amount of research has been published in this field, systematic evidence reviews demonstrated the poor quality of the published studies, meaning there is not a reliable evidence base upon which to make clinical decisions, or for children and their families to make informed choices.”   The Cass Review also found that “[t]he rationale for early puberty suppression remains unclear, with weak evidence regarding the impact on gender dysphoria, mental or psychosocial health,” as well as unknown effects on cognitive and psychosexual development.  In August 2024, the American Society of Plastic Surgeons (ASPS) became the first major U.S. medical association to express caution on the use of gender surgery for gender dysphoria in adolescents. In its formal statement, the association stated: “ASPS currently understands that there is considerable uncertainty as to the long-term efficacy for the use of chest and genital surgical interventions for the treatment of adolescents with gender dysphoria, and the existing evidence base is viewed as low quality/low certainty. This patient population requires specific considerations.”   The letter was signed by Committee Chair Cathy McMorris Rodgers (R-WA), Subcommittee on Health Chair Brett Guthrie (R-KY), Subcommittee on Oversight and Investigations Chair Morgan Griffith (R-VA), Rep. Dan Crenshaw (R-TX), Rep. Gus Bilirakis (R-FL), Rep. Buddy Carter (R-GA), Rep. Gary Palmer (R-AL), Rep. Neal Dunn (R-FL), Rep. Randy Weber (R-TX), Rep. Troy Balderson (R-OH), Rep. August Pfluger (R-TX), Rep. Diana Harshbarger (R-TN), and Rep. Kat Cammack (R-FL).  CLICK HERE to read the letter.



Nov 22, 2024
Press Release

E&C, E&W Republicans Press Gladstone Institutes for Information Regarding Internal Antisemitism

House Republicans scrutinize government grant funding recipients that fail to protect individuals from antisemitism Washington, D.C. — In a new letter to J. David Gladstone Institutes President Dr. Deepak Srivastava, the House Committee on Energy and Commerce (E&C) and House Committee on Education and the Workforce (E&W) have requested information about ongoing and pervasive acts of antisemitic harassment and intimidation at Gladstone and its leadership’s insufficient response to these acts. The letter is signed by E&C Chair Cathy McMorris Rodgers (R-WA), E&C Subcommittee on Health Chair Brett Guthrie (R-KY), E&C Oversight and Investigations Subcommittee Chair Morgan Griffith (R-VA), E&W Chair Virginia Foxx (R-NC), and E&W Subcommittee on Higher Education and Workforce Development Chair Burgess Owens (R-UT).  KEY LETTER EXCERPTS: “The Gladstone Institutes, an independent biomedical research organization, claims that it takes an active stance against serious issues like discrimination and harassment and aims to ‘ensure all community members at Gladstone feel included’ and that the Institutes will aim to ‘implement accountability measures and reinforce Gladstone’s commitment to having an environment free of harassment.’ However, these values do not seem to be reflected in the actions of leadership in response to recent concerns of antisemitic harassment and discrimination within the Institutes.” [...] “The reports of antisemitic harassment at Gladstone coupled with the inadequate response by leadership is concerning to the Committees. Failing to act decisively to ensure a safe environment for all trainees, faculty, and staff is a grave dereliction of your responsibilities as President of Gladstone.” “Failing to comply with basic safety protections for members of Gladstone or failure to respond appropriately to and prevent harassment and discrimination, no matter the cause, may be grounds to withhold federal funds from the university. Congress has an obligation to exercise oversight of recipients of federal funds when blatant and ongoing Title VI violations appear to be happening. If Congress determines an institution of higher education/research is blatantly ignoring its legal responsibilities, we may consider rescinding research and development funds previously appropriated.” BACKGROUND ON TAXPAYER FUNDING: Gladstone received more than $41 million in funding from the NIH in Fiscal Year 2023, not including potential taxpayer funding that individual faculty may have received through their affiliation with the University of California, San Francisco (UCSF) or any other affiliated universities.   According to the NIH’s Grant Policy Statement, any institution receiving federal funds must assure work environments are free of discriminatory harassment and are safe and conducive to high-quality work.  Institutions receiving federal taxpayer financial assistance—such as NIH grants—are prohibited from discriminating based on a variety of categories, including national origin.   These laws also protect members of the institution who are or are perceived to be members of a group with shared ancestry, such as students/trainees of Jewish heritage. BACKGROUND ON INSTANCES OF ANTISEMITISM : Two days after the October 7, 2023, Hamas terrorist attack, a graduate student working in a lab within Gladstone sent an antisemitic email to all Gladstone faculty, trainees, and staff falsely stating that the attack on innocent Israeli civilians was “the resistance in Gaza launch[ing] a surprise attack against Israel, taking occupation soldiers hostage, taking over Israeli military vehicles, and gain[ing] control over illegal Israeli settlements.”  The email goes on to claim that all casualties resulting from Palestinian actions are the responsibility of Israel.  Immediately following this mass email, members of the Gladstone faculty began contacting the Gladstone Institutes’ President and other leadership, appalled by the language of the email, concerned for their safety and worried that the email could be seen as an incitement to violence.  Jewish members of the Institutes also expressed their deep, personal pain following the Hamas attack, as some members had family or friends reported killed or missing directly after the attack.  These fears—including fears of being attacked in the lab by the author of this cruel and antagonistic email—were shared directly with President Srivastava.  Despite this, Gladstone leadership did not issue a public statement or position against antisemitism to quell fears of Jewish faculty and trainees.  In May 2024, the Center for Combatting Antisemitism sent President Srivastava a letter requesting administrative action to address the hostile environment and disparate treatment of Jewish members at Gladstone.  This letter noted that Gladstone refused to acknowledge Jewish American Heritage Month, Passover, or Holocaust Remembrance Day, despite sending official celebratory emails and holding events for other religious, ethnic, or national holidays, including Black History Month, International Women’s Day, and Ramadan.  The Center followed up with Gladstone several times, but never received a response.  Jewish faculty and trainees have conveyed to leadership within Gladstone instances of antisemitic harassment and discrimination, which faculty and trainees believe were not taken seriously, making some feel uneasy about speaking out.  For example, per a publicly available Fair Employment and Housing Act complaint to the California Civil Rights Division, a Jewish faculty member openly discussed fellow faculty using racial stereotypes, including comments about a “Jewish nose.”  When these comments were brought to human resources, no investigation occurred.  Instead, the complainant was subsequently targeted with an investigation ultimately deemed to be unwarranted.  Then, following the complainant’s post-October 7th advocacy on behalf of Jewish faculty and trainees, the complainant was threatened repeatedly with career-ending termination, allegedly in an attempt to extort a resignation.  When the threats did not have their desired effect, Gladstone placed the complainant on administrative leave and removed the complainant’s electronic access to email and files but also physical access to the complainant’s lab, removing all ability to conduct work on an NIH-funded grant.  Gladstone ultimately paid an undisclosed sum to settle the matter and avoid litigation.  To elevate concerns regarding widespread, ongoing discrimination, Jewish faculty and trainees requested permission to bring in a speaker related to antisemitism.  Other minority groups had previously been given permission to bring in similar anti-racism speakers.  However, while leadership stated it would look into the idea, ultimately no speaker was brought, and no program was launched regarding antisemitism. BACKGROUND ON AFFILIATIONS WITH OTHER INSTITUTIONS UNDER INVESTIGATION : Gladstone Institutes is affiliated with other institutions under congressional investigation.  For example, Gladstone is an affiliate of the UCSF, which is undergoing congressional investigation for reports of antisemitism within the university, medical school, and medical centers.  Most of Gladstone’s principal investigators are also faculty at UCSF, and the Institutes provide research positions and opportunities for graduate students from UCSF.  Moreover, there is a joint institute—the Gladstone-UCSF Institute of Genomic Immunology—further linking the two institutions.  Gladstone is also affiliated with the University of California, Berkeley and Stanford University, both of which are also under investigation for concerns related to antisemitism. CLICK HERE to read the full letter.